TrialClinical cancer research : an official journal of the American Association for Cancer Research2015

Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.

Hideho Okada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.